VIROCYT

ViroCyt focuses on the commercialization of novel technologies that enable the rapid quantification of viruses. Our goal is to provide the tools that deliver meaningful improvements to mission-critical processes, such as vaccine manufacturing, protein expression, antiviral development, and other settings where viruses play a significant role. It was founded in 2012 and is based in Broomfield, Colorado.